Literature DB >> 9326636

Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

S T Smiley1, S N Boyer, M J Heeb, J H Griffin, M J Grusby.   

Abstract

Extravascular procoagulant activity often accompanies cell-mediated immune responses and systemic administration of pharmacologic anticoagulants prevents cell-mediated delayed-type hypersensitivity reactions. These observations suggest a direct association between coagulation and cell-mediated immunity. The cytokine interleukin (IL)-4 potently suppresses cell-mediated immune responses, but its mechanism of action remains to be determined. Herein we demonstrate that the physiologic anticoagulant protein S is IL-4-inducible in primary T cells. Although protein S was known to inhibit the classic factor Va-dependent prothrombinase assembled by endothelial cells and platelets, we found that protein S also inhibits the factor Va-independent prothrombinase assembled by lymphoid cells. Thus, protein S-mediated down-regulation of lymphoid cell procoagulant activity may be one mechanism by which IL-4 antagonizes cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326636      PMCID: PMC23513          DOI: 10.1073/pnas.94.21.11484

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  The effects of anticoagulants and other drugs on cellular and cutaneous reactions to antigen in guinea-pigs with delayed-type hypersensitivity.

Authors:  D S Nelson
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

2.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Authors:  M H Kaplan; U Schindler; S T Smiley; M J Grusby
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

3.  The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit organs as demonstrated by northern blotting, in situ hybridization, and immunohistochemistry.

Authors:  X He; L Shen; A Bjartell; B Dahlbäck
Journal:  J Histochem Cytochem       Date:  1995-01       Impact factor: 2.479

4.  Effect of anticoagulants on delayed hypersensitivity reactions.

Authors:  S Cohen; B Benacerraf; R T McCluskey; Z Ovary
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

5.  Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding.

Authors:  G Ambrosini; D C Altieri
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

6.  In vivo immunosuppression by targeting a novel protease receptor.

Authors:  M A Duchosal; A L Rothermel; P J McConahey; F J Dixon; D C Altieri
Journal:  Nature       Date:  1996-03-28       Impact factor: 49.962

7.  Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats.

Authors:  P Y Paterson
Journal:  Fed Proc       Date:  1976-11

8.  Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.

Authors:  T M Hackeng; C van 't Veer; J C Meijers; B N Bouma
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

9.  Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

Authors:  S T Grey; A Tsuchida; H Hau; C L Orthner; H H Salem; W W Hancock
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

10.  Thrombin functions as an inflammatory mediator through activation of its receptor.

Authors:  G Cirino; C Cicala; M R Bucci; L Sorrentino; J M Maraganore; S R Stone
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  15 in total

1.  Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.

Authors:  W Gao; P S Topham; J A King; S T Smiley; V Csizmadia; B Lu; C J Gerard; W W Hancock
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 2.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 3.  Biology of the TAM receptors.

Authors:  Greg Lemke
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

Review 4.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

Review 5.  Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.

Authors:  Carla V Rothlin; Jonathan A Leighton; Sourav Ghosh
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

Review 6.  Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

Authors:  Silvina Del Carmen; Sophie M Hapak; Sourav Ghosh; Carla V Rothlin
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

7.  T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.

Authors:  Eugenio A Carrera Silva; Pamela Y Chan; Leonel Joannas; Andrea E Errasti; Nicola Gagliani; Lidia Bosurgi; Maurice Jabbour; Anthony Perry; Faye Smith-Chakmakova; Daniel Mucida; Hilde Cheroutre; Tal Burstyn-Cohen; Jonathan A Leighton; Greg Lemke; Sourav Ghosh; Carla V Rothlin
Journal:  Immunity       Date:  2013-07-11       Impact factor: 31.745

Review 8.  TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.

Authors:  Yemsratch T Akalu; Carla V Rothlin; Sourav Ghosh
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

9.  Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis.

Authors:  Tal Burstyn-Cohen; Erin D Lew; Paqui G Través; Patrick G Burrola; Joseph C Hash; Greg Lemke
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

10.  Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2.

Authors:  Wayne W Hancock; Frank M Szaba; Kiera N Berggren; Michelle A Parent; Isis K Mullarky; John Pearl; Andrea M Cooper; Kenneth H Ely; David L Woodland; In-Jeong Kim; Marcia A Blackman; Lawrence L Johnson; Stephen T Smiley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.